Swollen Toe, Tip of the Iceberg–Assessing and Managing Hyperuricemia and Gout

Both hyperuricemia and gout are increasingly prevalent in the United States, though there are often deficits surrounding diagnosis, ongoing assessment and management. In two 15-minute discussions, listen as two experts discuss case-based examples of gout, providing clinicians with knowledge and increased competence for managing patients with gout.

TARGET AUDIENCE

This activity has been designed to meet the educational needs of health care professionals involved in the diagnosis, treatment, or management of patients with gout.

EDUCATIONAL OBJECTIVES

Upon completion of this activity, participants will be better able to do the following:

  1. Formulate an accurate gout diagnosis primarily on the basis of clinical evaluation
  2. Describe when and how to conduct a joint aspiration and injection
  3. Use evidence and/or expert opinion, as well as individual patient characteristics, to guide treatment selection for both acute and chronic gout
  4. Develop an evidence-based plan for assessing response to gout treatment

FACULTY

Paul Doghramji, MD, FAAFP
Medical Director of the Wellness Center
Ursinus College
Collegeville, PA

Brian Koffman, MDCM, DCFP, DABFM, MS Ed
Clinical Professor (retired) Family Medicine
Keck School of Medicine
USC Family Practice
St. Jude Heritage Medical Group
Diamond Bar, CA
Chief Medical Officer, CLL Society
Claremont, CA

Disclosure of Conflicts of Interest

It is the policy of the Elsevier Office of Continuing Medical Education that all faculty, instructors, and planners disclose any real or apparent conflicts of interest relating to the topics of this educational activity. 

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or PresenterRelationship Identified With:
Paul Doghramji, MD, FAAFP

Consultant/Advisor: Ironwood Pharmaceuticals, Inc.

Speakers’ Bureau: Ironwood Pharmaceuticals, Inc.
Brian Koffman, MDCM, DCFP, DABFM, MS Ed

Consultant/Advisor: Novartis AG; Verastem, Inc.

Stock ownership: AbbVie Inc.; AstraZeneca; Bristol-Myers Squibb Company; Gilead; Johnson & Johnson Services, Inc.; MEI Pharma Inc; Sunesis Pharmaceuticals, Inc.; Verastem, Inc. (spouse has ownership also)

Non-Faculty: Eve Wilson, PhD, CHCP; Sandy Breslow; Alison Kemp; and Bernard M. Abrams, MD hereby state that neither they nor their spouse/life partner have had any financial relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Financial Support

This activity has been supported by an independent educational grant from Ironwood Pharmaceuticals, Inc.

Provider Information

Provided by the Elsevier Office of Continuing Medical Education in collaboration with The France Foundation.

CME Credit (Physicians)

The Elsevier Office of Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Elsevier Office of Continuing Medical Education designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 CreditTM issued by organizations accredited by the Accreditation Council for Continuing Medical Education (ACCME) for the purpose of reaccreditation for both nurse practitioners and registered nurses

The National Commission on Certification of Physician Assistants (NCCPA) accepts AMA PRA Category 1 CreditTM issued by organizations accredited by the ACCME for Category 1 CME credit activities for physician Assistants. 

CME Inquiries/Special Needs

For all CME inquiries or special needs, please contact elsevierCME@elsevier.com.


Disclosure of Unlabeled Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Elsevier Office of Continuing Medical Education, The France Foundation, and Ironwood Pharmaceuticals, Inc., do not recommend the use of any agent outside of the labeled indications.

Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit(s)™
  • 0.50 Non-physician
Course opens: 
11/01/2018
Course expires: 
10/31/2019
Rating: 
0

Available Credit

  • 0.50 AMA PRA Category 1 Credit(s)™
  • 0.50 Non-physician

Accreditation Period

Course opens: 
11/01/2018
Course expires: 
10/31/2019
Please login or register to take this course.